Biotech Stocks Hit 52-Week Highs on Clinical, Earnings Catalysts; OMER Jumps 13%

Several biotech stocks reached 52-week highs on September 22, 2026, lifted by positive quarterly reports and clinical trial results. Omeros Corp. (OMER) surged 13%, while Teknova Inc. (TKNO) gained 5%. BioLife Solutions (BLFS), Schrödinger (SDGR) and InfuSystem Holdings (INFU) also touched new annual peaks. The advances reflect renewed investor appetite for the sector, with company-specific catalysts — including trial data readouts and earnings beats — driving the outsized moves rather than broad market momentum. Traders are watching whether the rally sustains into the fourth quarter as additional clinical data and quarterly results are released.